Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can mindful eating help french adults manage weight?

NCT ID NCT06157411

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new mindful eating program designed for French adults with overweight or obesity. Fifty-six participants joined group sessions and home exercises to improve their eating awareness. The goal was to see if the program could increase mindful eating and reduce anxiety and depression. It aims to fill a gap in weight management options in France.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindful eating program (behavioral intervention)
What this could lead to
If it works, this could provide a new, practical tool to help French adults with overweight or obesity improve their relationship with food and reduce anxiety.
What could go wrong
This is a small, completed study with only 56 participants, so results may not apply to everyone. The program requires time and effort, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

Feb 2024

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * First visit to the Nutrition and Diabetes Unit of Montpellier University Hospital for overweight/obesity * Adults aged 18 and over, volunteers * BMI ≥ 25kg/m² and ≤ 50kg/m² * Provisional verbal consent followed by signed written consent Exclusion Criteria: * People who are illiterate or suffer from a major cognitive impairment that prevents them from understanding the study and the mindful eating program * Pregnant or breast-feeding women * People who are taking medicines that may have an effect on their weight (especially GLP-1 analogs, neuroleptics, corticosteroids) * Anyone with a history of bariatric surgery or scheduled bariatric surgery within the next 6 months * Presence of co-morbidities or severe pathologies (in particular respiratory failure, heart failure, cancer) * Diagnosis of severe psychiatric disorder (in particular schizophrenia, bipolar disorder), depressive syndrome, or suicidal behavior in the past year * People suffering from genetic or syndromic obesity * Lack of Internet access * Person currently participating in another interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight and obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Antoine Avignon

    Montpellier, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.